Who owns Salix Pharmaceuticals Inc note 2.750% 5/1?

Key details on Salix Pharmaceuticals Inc note 2.750% 5/1

Who owns Salix Pharmaceuticals Inc note 2.750% 5/1?

Is Salix Pharmaceuticals Inc note 2.750% 5/1 a good stock to own? Find out who bought Salix Pharmaceuticals Inc note 2.750% 5/1, who sold Salix Pharmaceuticals Inc note 2.750% 5/1 stock, and who holds a large position in Salix Pharmaceuticals Inc note 2.750% 5/1.

Fund Name Number of Shares Share Valuation As Of
Baker Bros. Advisors 219.44M $737.32M Sept. 30, 2014
Wolverine Asset Management 33.09M $111.18M Sept. 30, 2014
Steelhead Partners 28.79M $33.11M Dec. 31, 2012
HIGHBRIDGE CAPITAL MANAGEMENT 28.20M $94.75M Sept. 30, 2014
AVIVA 25.00M $38.25M Sept. 30, 2013
Prudential 19.16M $29.32M Sept. 30, 2013
Inves 15.90M $18.61M Sept. 30, 2012
Polar Securities 13.25M $15.24M Dec. 31, 2012
Citi 13.01M $43.71M Sept. 30, 2014
Franklin Resources 12.00M $40.32M Sept. 30, 2014
Bank of America Corporation 11.95M $23.91M Dec. 31, 2013
Symphony Asset Management 11.73M $39.52M Sept. 30, 2014
Mason Street Advisors 11.00M $14.19M Dec. 31, 2011
BlackRock Institutional Trust Company, N.A. 8.02M $21.41M June 30, 2014
CITADEL ADVISORS 6.00M $20.16M Sept. 30, 2014
RWC Asset Management 5.98M $7.00M Sept. 30, 2012
GOLDMAN SACHS 5.87M $13.16M March 31, 2014
LORD, ABBETT & CO 5.49M $14.72M June 30, 2014
Palisade Capital Management 5.13M $6.87M March 31, 2012
Nicholas Investments Partners 5.00M $7.65M Sept. 30, 2013
MacKay Shields 4.21M $6.39M June 30, 2013
CALAMOS ADVISORS 4.20M $5.42M March 31, 2013
Capstone Investment Advisors 3.00M $8.01M June 30, 2014
Daiwa Securities 2.92M $3.42M March 31, 2013
JPMORGAN CHASE & CO 2.28M $7.66M Sept. 30, 2014
Wells Fargo & Company 2.20M $3.35M June 30, 2013
SSI Investment Management 2.16M $2.79M March 31, 2013
Visium Asset Management 2.00M $6.74M Sept. 30, 2014
Geode Capital Management 2.00M $5.34M June 30, 2014
Advent Capital Management 1.83M $2.78M June 30, 2013
BNP PARIBAS ARBITRAGE, SNC 1.72M $261.11M June 30, 2013
CALAMOS WEALTH MANAGEMENT 1.51M $1.78M Sept. 30, 2012
SAGE CAPITAL MANAGEMENT 1.50M $2.29M Sept. 30, 2013
Allianz Asset Management AG 1.50M $1.73M Dec. 31, 2012
GRACE BROTHERS MANAGEMENT 1.50M $2.01M March 31, 2012
Credit Agricole S.A. 1.46M $1.89M March 31, 2013

Who sold Salix Pharmaceuticals Inc note 2.750% 5/1?

Fund Name Date Sold Number of Shares Sold Share Valuation
Oaktree Capital Management Dec. 31, 2012 4.50M $5.17M
Northwestern Investment Management Company June 30, 2011 16.00M $16.80M
Ameriprise Financial June 30, 2011 2.59M $2.98M